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Abstract: Individuals with type 1 diabetes (T1D) are able to balance their blood glucose levels while
engaging in a wide variety of physical activities and sports. However, insulin use forces them to
contend with many daily training and performance challenges involved with fine-tuning medication
dosing, physical activity levels, and dietary patterns to optimize their participation and performance.
The aim of this study was to ascertain which variables related to the diabetes management of physi-
cally active individuals with T1D have the greatest impact on overall blood glucose levels (reported
as A1C) in a real-world setting. A total of 220 individuals with T1D completed an online survey
to self-report information about their glycemic management, physical activity patterns, carbohy-
drate and dietary intake, use of diabetes technologies, and other variables that impact diabetes
management and health. In analyzing many variables affecting glycemic management, the primary
significant finding was that A1C values in lower, recommended ranges (<7%) were significantly
predicted by a very-low carbohydrate intake dietary pattern, whereas the use of continuous glucose
monitoring (CGM) devices had the greatest predictive ability when A1C was above recommended
(≥7%). Various aspects of physical activity participation (including type, weekly time, frequency,
and intensity) were not significantly associated with A1C for participants in this survey. In conclu-
sion, when individuals with T1D are already physically active, dietary changes and more frequent
monitoring of glucose may be most capable of further enhancing glycemic management.
Keywords: type 1 diabetes; A1C; physical activity; exercise; athletes; blood glucose; diet; CGM
1. Introduction
In 2021, a full century has passed since the 1921 discovery of insulin [1], a hormone
that must be replaced in individuals with type 1 diabetes (T1D), all of whom have lost the
ability to produce it as the result of primarily autoimmune destruction of the pancreatic
β-cells [2]. Since its discovery, replacement insulin has evolved greatly with numerous
types and delivery methods now possible, along with use of better glycemic management
and tracking tools that can assist individuals in preventing acute and chronic diabetes-
related health complications. In fact, most people with T1D can expect to experience near
normal longevity with a high quality of life, particularly if glycemic management and
cardiovascular health are maintained [3].
When undertaken by individuals of all ages with T1D, physical activity is associated
with many well-established health benefits, including improved cardiovascular fitness,
lower cardiovascular risk, better quality overall health, and enhanced psychological well-
being [4,5]. One of the major factors linked with their long-term survival is the absence
of features of the metabolic syndrome and, more specifically, the presence of insulin
sensitivity [6]. Physical activity of all types has been associated with greater insulin
sensitivity [7–9]. In adults with T1D, being regularly active improves cardiometabolic risk
profile [10] and is associated with increased longevity [6,11]. Individuals with T1D of all
ages are capable of engaging in a wide variety of physical activities and sports, ranging
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from recreational to Olympic-level (12), and many choose to be physically active to achieve
unique goals related to athletics and/or health. However, these individuals must contend
with the continuous challenges associated with being physically active with T1D, including
monitoring glucose levels, managing dietary choices and intake, adjusting insulin doses,
and adapting daily regimens to account for other factors that impact glycemia [12–15].
Physical activity acutely can lead to hypoglycemia and hyperglycemia [15–20], either of
which may become a medical emergency if not adequately managed.
Numerous physical activity training patterns and regimens are possible with T1D,
and each individual must choose to follow the one that works uniquely best, although
that may vary with the type, intensity, frequency, and timing of activities, among other
variables [18,19,21,22]. High-intensity training as well as competition can substantially
increase glucose output from the liver, potentially leading to hyperglycemia both before
and during activity [19]. Resistance exercise is associated with less of a decline in blood
glucose than aerobic [18,23] and can provide a protective effect against glycemic declines if
performed prior to aerobic exercise [24]. Even the timing of exercise can impact outcomes,
with exercise before breakfast resulting in less hypoglycemia than the same bout of aerobic
or resistance activity undertaken later in the day [18,23,25]. An appropriate dose of rapid-
acting insulin can be used to treat hyperglycemia after morning exercise of any type without
inducing hypoglycemia post-exercise [26]. In addition, exercise glycemic management
strategies often vary within sporting events [27,28] and afterward [20,28].
In addition, nutrition and dietary patterns are one of the more controversial topics
related to athletic performance in all individuals, as well as to glycemic management
in T1D and overall health [12,13,29–31]. Whether individuals are participating in sports
and activities recreationally or aiming for competitive levels of athletic achievement, their
performance can be positively or negatively impacted by a number of nutritional factors,
such as intake and timing of macronutrients, availability of micronutrients, hydration status
and electrolyte balance, and exercise training practices [12–14]. In particular, carbohydrate
consumption to fuel the exercise bout and/or for hypoglycemia prevention is an important
cornerstone to maintain performance and avoid hypoglycemia [31,32].
Use of some of the insulin delivery systems, glucose monitoring devices, algorithms,
other glucose-focused technology and tools may also improve how well activity can be
managed [26,33–35]. Recent technological advances, such as insulin pumps and continuous
glucose monitoring (CGM) devices, have greatly advanced the ability of individuals to
manage glucose levels around physical activity by allowing for almost real-time changes
in insulin delivery and feedback on glycemic responses [36,37]. When using continuous
subcutaneous insulin infusion (i.e., an insulin pump), active individuals can reduce or
suspend basal insulin infusion at the start of exercise [38], or even starting 30–60 min
before exercise [39], in order to mitigate declines in blood glucose. Likewise, CGM devices
have been shown to improve glycemic management [40–42], even in individuals with
T1D with lower A1C (a measure of overall blood glucose over the last 2–3 months) values
already [43]. However, CGM measure glucose in interstitial spaces, and a time lag exists
between blood glucose (measured via finger stick) and CGM glucose levels (measured
via CGM) [36,44,45], making it unclear whether use of such devices can benefit glycemic
management with physical activity. Finally, integrated insulin pump and CGM systems
have shown promise with regard to ameliorating glycemic management in individuals
with T1D [35,46–48], but their successful use around exercise remains more limited [49–54].
Thus, the purpose of this study was to ascertain which variables related to the diabetes
management of physically active individuals with T1D have the greatest impact on overall
blood glucose levels (via A1C) in a cohort of active adults and adolescents with T1D
in a real-world setting. Given the complexity of managing blood glucose levels when
exogenous insulin must be precisely balanced with food intake for any physical activity,
we hypothesized that both physical activity (total weekly time, frequency, intensity, and/or
type) and dietary patterns (particularly carbohydrate intake) would potentially impact
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overall blood glucose management in these active individuals, along with the use of the
latest diabetes technologies (e.g., insulin pumps and CGM devices).
2. Materials and Methods
2.1. Subject Recruitment
An online survey conducted in English was advertised in 2018 by investigators on
diabetes-focused social media platforms and distributed to various professional contacts
via email. Participation was completely voluntary with no incentives offered, and the
survey was open to all physically active individuals with diabetes of any age during a
month-long period. The survey itself was completed through a separate online platform
and contained no questions that could be used to identify personal data or characteristics
by the investigators. Data collection methods were considered exempt from requiring
participant consent by our university due to the online anonymous and voluntary nature
in which all survey responses were obtained and recorded.
A total of 220 participants (109 male, 111 female, age range of 13 to 84 years) who had
been diagnosed with T1D for varying lengths of time were included in the study. Their
distributions by age and years with T1D are shown in Figure 1.
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individualized diabetes regimen changes were collected for over 165 different sports and
activities, which were largely used for other purposes [55]. Responses to these physical
activity and other related, open-ended questions were not directly analyzed and only
included in terms of whether participants reported engaging in various activities.
Participants’ self-reported activities were placed into one or more of five categories:
fitness, endurance, endurance-power, power, and outdoor. The designation of each sport
was determined by the investigators and primarily based on the energy systems engaged
during the activity itself (aerobic vs. anaerobic ones) [56], although some overlap among
categories exists for certain sports and activities. Once participants answered “yes” for a
category, numerous examples of activities and sports in each category were provided in the
survey as drop-down selections to steer them to select representative ones. Some examples
of selections in each category included, but were not limited to, the following:
• Fitness activities: fitness walking, aerobic conditioning machines, resistance training,
aerobics classes, Pilates, kettle ball training, dancing, agility training, balance training,
stretching, yoga, indoor climbing, martial arts, tai chi, physical activity classes;
• Endurance activities/sports: running and jogging, swimming, cycling, marathons,
biathlons, triathlons, cross-country running or skiing, ultra endurance training;
• Endurance-power sports: basketball, soccer, golf, tennis, hockey, football, tennis,
indoor racquet sports, intermediate-distance track events, CrossFit, high-intensity
interval training;
• Power sports: baseball, bodybuilding, Olympic weight lifting or power lifting, sprint-
ing, field events (shot put, pole vault, high jump, etc.), volleyball or beach volleyball;
• Outdoor activities/sports: kayaking, downhill skiing, curling, waterskiing or wake-
boarding, kiteboarding, hiking and backpacking, horseback riding, rock or ice climb-
ing, adventure racing, trail running, hunting, fishing, gardening, etc.
2.2.2. Dietary Patterns and Carbohydrate Intake
The usual dietary patterns of participants were assessed with specific questions about
whether they ingested carbohydrate for physical activity, their preferred sport-specific
carbohydrate choices, and their usual dietary treatments for hypoglycemia, along with
more open-ended questions about their typical dietary patterns. Some responded with
definitive dietary patterns from which carbohydrate intake could be easily estimated,
such as “keto diet” [57] or “Dr. Bernstein diet” [58,59], whereas others gave actual daily
carbohydrate estimates or stated that they were vegan or vegetarian, ate a meat-based diet,
consumed a plant-based whole foods diet, or avoided/limited their intake of starches or
other food categories. These carbohydrate intake/dietary pattern data have been reported
for a larger cohort of individuals with T1D or type 2 diabetes previously [12,13]. All of
their responses to nutrition-related or dietary questions were considered together by the
investigators, along with typical calorie requirements for active adults and adolescents [60],
when estimating participants’ generalized daily carbohydrate intake and placing them into
one of four categories for analyses:
• Normal (unrestricted): >200 g/day;
• Moderate: 100–200 g/day;
• Low-carbohydrate: 40–99 g/day;
• Very low-carbohydrate: <40 g/day.
2.3. Statistical Analyses
For this study, descriptive variables are presented as mean, standard error of the mean
(SE), median, minimum, and maximum. A generalized linear model (GLM) approach was
used to measure and quantify association between A1C and predictor variables. Using
GLM, the equation for these associations was formulated as:
yi = β0 + β1x1i + β2x2i + . . . + βpxpi + ei,
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where yi represents the response of the ith participant’s A1C, for i = 1, . . . , n, with
x1, x2, . . . , xp representing other predictors like biological sex, usual carbohydrate intake,
use of CGM devices, and other collected variables. Predictor variables were either dis-
crete or continuous. In the model equation, the term β0 served as the model intercept
and βi referred to the slope associated with the ith predictor variable, with the errors




and σ2 with the model variance.
In order to minimize variance and satisfy model assumptions, a transformation of the A1C
to a natural log scale was applied.
Due to a gap in self-reported A1C values, the natural log values (log A1C) were found
to be closer to the normal distribution than the A1C itself. Consequently, log A1C values
were used for further analyses in the GLM (see Appendix A for a detailed justification of
the transformation to natural log and results of statistical tests). Significance for all such
analyses was set as p < 0.05.
3. Results
3.1. Participant Characteristics and Survey Responses
The demographic factors of participants included their A1C, age, and years living with
diabetes, as shown in Table 1, along with responses to other quantifiable and categorical
questions from the online survey. The majority of the 220 respondents were from the
United States (68%), with others from Europe (13%), Canada (7%), Australia (6%), Eastern
Europe (3%), and the rest (3%) from Mexico, South Africa, Iran, India, and the Philippines.
Data from another 30 participants with T1D were excluded due to incomplete or missing
responses related to A1C and other relevant variables.
Table 1. Participant Characteristics and Survey Question Responses.
Characteristic or Survey Question N Mean Median SE Min Max
Latest A1C (%) 220 6.6 6.6 0.1 4.2 10.5
Age (years) 220 42.1 40 1 13 84
Time with T1D (years) 220 21 18 1 1 80
Total weekly physical activity (minutes) 220 498 360 26 30 2520
Total weekly physical activity (hours) 220 8.3 6 0.4 0.5 42
Days per week of physical activity (number) 220 5.2 5 0.1 2 7
Typical duration of physical activity (minutes) 220 93 75 5 15 720
Carbohydrate intake (1 = normal to 4 = very low) 220 2.1 2 0.1 1 4
Ingest carbs if glucose falls with activity (yes/no) 220 1.07 1 0.02 1 (yes) 2 (no)
Insulin pump use (yes/no) 220 1.4 1 0.03 1 (yes) 2 (no)
Noninsulin diabetes medication use (yes/no) 220 1.86 2 0.02 1 (yes) 2 (no)
Statin use to lower blood cholesterol (yes/no) 220 1.71 2 0.03 1 (yes) 2 (no)
Self-monitor blood glucose (yes/no) 220 1.05 1 0.02 1 (yes) 2 (no)
Continuous glucose monitor use (yes/no) 220 1.22 1 0.03 1 (yes) 2 (no)
Fitness activities (yes/no) 220 1.18 1 0.03 1 (yes) 2 (no)
Endurance sports or training (yes/no) 220 1.29 1 0.05 1 (yes) 2 (no)
Endurance-power sports (yes/no) 220 1.75 2 0.03 1 (yes) 2 (no)
Power sports or training (yes/no) 220 1.86 2 0.02 1 (yes) 2 (no)
Outdoor recreational activities (yes/no) 220 1.53 2 0.03 1 (yes) 2 (no)
Exercise-induced low blood glucose (yes/no) 220 1.13 1 0.02 1 (yes) 2 (no)
Exercise-induced high blood glucose (yes/no) 220 1.32 1 0.03 1 (yes) 2 (no)
As a whole, the participants’ latest A1C mean and median values (Table 1) were well
within commonly recommended ranges of less than 7% [61]. Almost 70% self-reported
having an A1C within this recommended range, although values ranged from 4.2% to
10.5%. About 25 individuals reported using a second diabetes medication besides insulin,
with the majority of them using either metformin or a sodium-glucose transport protein 2
(SGLT2) inhibitor. As none of these medications impacts exercise-associated blood glucose
levels, they were not included in any further analyses.
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3.2. AIC and Its Predictors
3.2.1. A1C Prediction with Physical Activity Variables
The total weekly time spent being physically active was estimated based on participant
responses to both frequency (number of days per week) and usual time spent exercising
on active days. The total hours per week were calculated as a product of the two, and the
distribution of participant time is shown in Figure 2. The nature of the survey did not allow
for any differentiation among time spent doing different types of activities.
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individuals with T1D do not necessarily experience improvements in overall glucose
values when regularly active, with some studies demonstrating benefits [64–66] and others
finding no improvement in A1C following aerobic or resistance training [67,68]. Our
participants were engaging in myriad activities, though, making interpretation more
difficult compared to those studies and others in which activities were more controlled and
uniform. Moreover, our survey respondents engaged in physical activity 2 to 7 days per
week, with over 93% of them reportedly engaging in more than the minimal recommended
time. Some were training up to 42 h of weekly as competitive athletes and only five
participants were active less than 100 min per week. This level of participation is far
more than in the population overall [69,70] and for most with diabetes [71]. While our
survey was not capable of discerning time spent in aerobic (as recommended 150 to 300
or more minutes a week) versus other types of activities, others have shown that total
exercise volume and time spent being physically active doing any type of activity may
matter more to cardiovascular and metabolic health than participation in specific bouts
of moderate-to-vigorous aerobic activities by themselves [72–75]. Engaging in muscle-
strengthening activity ≥2 times/week may provide additional benefits among insufficiently
active adults [76]. With these observations in mind, we felt comfortable categorizing our
participants as meeting or failing to meet the recommended total activity time with all
types of activities considered together, not just aerobic ones.
Being physically active with T1D increases an individual’s risk of activity-related
hypoglycemia [77–79] and hyperglycemia [80,81], and fear of activity-related hypoglycemia
has often been a deterrent of regular participation for insulin users of all ages [82,83].
Conversely, since all of our participants were engaging in regular physical activity, they
likely had already adapted their diabetes management strategies to better manage their
glycemic variations while minimizing any fear of hypoglycemia associated with being
active; in fact, out of 220 participants, only 10 reported A1C values of 8% or higher and only
two of those were above 9%. Their regular participation may also at least partly explain
why their total activity was not predictive of overall glycemic management since the vast
majority were already exceeding recommended levels of activity and had A1C values that
were well-managed compared to the majority of individuals with T1D as a whole [41,42].
Thus, it is likely that the glycemic impact of being active was already reflected in their
having better A1C values than most individuals with T1D.
Another challenge associated with attempting to achieve better A1C values with phys-
ical activity is the unpredictability of glucose responses even to similar bouts of exercise.
Active individuals completing our online survey frequently expressed frustrations with
maintaining glycemic balance while doing a variety of physical activities under free-living
conditions [55]. A recent study conducted on 12 adults with T1D reported that three
identical cycling sessions completed on separate days under controlled conditions resulted
in varying values for glucose measured either with a finger-stick (capillary blood) blood
glucose monitor or a CGM device, even though glucose declined in all three trials [78]; these
results indicated low reproducibility at the participant level and remained unchanged after
adjustment for baseline glucose values. Likewise, in adolescents with T1D, while greater
intrasubject reliability and repeatability of blood glucose responses to prolonged exercise
was shown to be possible, this result occurred only when pre-exercise meal, exercise, and
insulin regimens were kept constant [84], which is not always feasible in real life. However,
recent technological advances, improvements in insulin regimens, newer insulins, and a
better understanding of the physiology of various types of exercise may help limit such
unpredictability for similar activities and, at the same time, lessen the fear of hypoglycemia
by facilitating hypoglycemia prevention [82]. With proper management around activities,
athletes with T1D at all levels have been shown to be capable of undertaking and per-
forming well even in long endurance training, high-intensity sports, and other types of
events [27,29,85,86].
With regard to dietary patterns, in the current study a very-low carbohydrate intake
was surprisingly most predictive of achieving recommended glycemic levels overall (i.e.,
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an A1C < 7%), regardless of differing levels and types of physical activity participation.
Many endurance athletes with and without T1D have claimed to perform well with a
lower, or at least moderate, intake of this macronutrient [57,87] and to maintain a better
glycemic balance [31], although the consensus remains that carbohydrates are necessary to
perform well at higher intensities and durations of activity [12,88,89]. However, the active
individuals in our study who stated that they ingest carbohydrates during physical activity
had similar A1C values to those who claimed to refrain from carbohydrate supplementation.
In fact, supplementing with carbohydrates has been shown to potentially be superior to
bolus insulin reduction for prevention of hypoglycemia during physical activity, as was
demonstrated in a group of adults with T1D engaging in moderate-intensity cycling for
45 min in one study [90]. In our survey, however, both strategies (i.e., carbohydrate
ingestion and insulin reduction) were used by most participants to prevent hypoglycemia
with activity; in many cases, active individuals with T1D must employ a combination of
both in order to maintain glycemic balance during and after training or events [12,15,29].
Nowadays, daily carbohydrate intake alone is usually not predictive of A1C values
for most with T1D, and consuming carbohydrates can be feasible, which may be reflective
of individuals’ use of faster-acting insulin analogues for meal boluses. In fact, a single
mealtime bolus of insulin has been shown to cover a range of carbohydrate intake without
deterioration in postprandial glycemia [91]. Even dietary fat, protein, and the glycemic
index of ingested carbohydrates are associated with insulin dosing needs and impact
postprandial glucose excursions [92,93], making glycemic predictions and insulin dos-
ing based on grams of carbohydrate intake alone inadequate. Carbohydrate counting is
fraught with complications given the complexities in digestion and absorption rates of
that macronutrient and challenges related to proper estimation of the amount ingested by
individuals [94–96]. With regard to our survey participants, most of whom already had
optimal blood glucose management, it may be that they simply were able to tighten it
slightly further by restricting their carbohydrate intake. Avoiding greater fluctuations in
blood glucose after meals and during activity can improve overall glycemia [97]. In our
survey, for individuals with higher-than-recommended A1C values, carbohydrate restric-
tion was not predictive of better glycemic management, suggesting that other variables are
impacting glycemia more in their case.
Although trials are undergoing, to date low- and very low-carbohydrate diets have not
been extensively studied in the management of T1D [13], with available studies examining
glycemic outcomes from such diets being largely cross-sectional and lacking validated
dietary data or control subjects [32,98]. Many of the participants in such studies can be
described as highly motivated individuals who follow intensive insulin management
practices, including frequent blood glucose monitoring and additional insulin corrections
to meet tight glycemic targets. While athletes may still perform adequately when following
such restricted diets [32,99,100], some potential negative health consequences of ketogenic
and other low-carbohydrate diets have been noted [101,102], and longer term studies are
needed to determine how feasible these dietary patterns are for most individuals with
T1D [103]. Thus, much work remains to be done to fully determine the extent of the
impact of dietary carbohydrate restriction on glycemic outcomes and optimal intake levels,
particularly in physically active individuals with T1D.
Finally, the use of the latest diabetes technological advances, such as insulin pumps
and CGM devices, has greatly advanced the ability to manage glucose levels around physi-
cal activity [36,37]. While 60% of our participants used an insulin pump, an even larger
percentage (77%) used a CGM. Having access to either one or both devices potentially can
allow users to make more informed choices to manage glycemia around exercise [104]. For
our survey participants, using a CGM device was predictive of lower A1C values (specif-
ically when above recommended levels) although insulin pump use was not predictive.
This is unsurprising given that other studies have shown that CGM can be beneficial for all
individuals with T1D [40–42], even for those who have already achieved recommended
A1C at <7.0% [43]. Despite the demonstrated time lag between blood glucose (measured
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via finger stick) and interstitial glucose levels (measured via CGM) [36,44,45], having closer
to real-time feedback on the impact of any activity likely makes glycemic management
easier, especially when activities can vary so widely in their effects. For instance, a recent
systematic review and meta-analysis that included 12 studies using CGM devices to exam-
ine the delayed impact of engaging in various physical activities reported that intermittent
exercise (i.e., most endurance-power or power sports) actually increases the time spent
in hypoglycemia and lowers mean glycemic values via CGM, with no differences in time
spent in hyperglycemia or the number of hypoglycemic events [105]. Hypoglycemia risk
was also lower for activities performed in the morning rather than in the afternoon, even
with a 50% rapid-acting insulin reduction prior to later-day exercise. While our partici-
pants did not indicate their usual time of day for activities, CGM use has the potential
to provide feedback that allows users to take corrective actions to manage glycemia in a
timelier manner.
Although not a survey question, some of our participants noted employing various
exercise strategies with use of hybrid closed-loop systems (i.e., Medtronic 670G), which
involve integration of an insulin pump, CGM, and algorithm control system to manage
insulin delivery in response to real-time glucose levels with minimal user input. Although
some input is usually still required (such as announcement of meals or exercise), hy-
brid systems have recently been found to improve time-in-range (typically defined as
70–180 mg/dL, or 3.9–10.0 mmol/L) around physical activity [106]. Users of such systems
with a lower intake of daily carbohydrates have also experienced better glycemic manage-
ment [107], likely due to the ability of such systems to make adjustments in response to the
slower glucose fluctuations resulting from dietary protein and fat [97,108].
The limitations of this survey research localize mainly around our inability to collect
more quantifiable and directly verifiable data, since all of it was self-reported and many
of the survey questions were more open-ended. This is particularly an issue for dietary
considerations including estimating carbohydrate intake, total calories, macronutrient
distribution, and micronutrient adequacy, among other considerations. The authors used
their best judgment when placing the participants into dietary categories for carbohydrate
intake based on the data collected. However, it is possible that their interpretation of some
responses was flawed or that participants failed to report or recognize all the carbohydrate
sources in their diets, including those in high-fat, low-carbohydrate foods (e.g., olives,
avocados, and nuts); in foods, drinks, or sports supplements taken during activities; and
in rapid hypoglycemia treatments. A dietary recall questionnaire would have enhanced
the reliability of these data around dietary patterns, total calorie intake, and macronutrient
distribution. Likewise, although participants responded to questions around insulin use,
types, and delivery methods, our interpretations are limited. More information related to
actual dosing, timing, and other insulin-related data, particularly around physical activity
and glycemic management would have provided more definitive results. Finally, relying on
self-reported data in any research study has its limitations and can be problematic [109,110];
this is particularly true when it comes to data related to physical activity. Our survey
participants reported engaging in a wide array of physical activities, many of which have
varied glucose responses even within a specific category, especially “outdoor activities and
sports”. Our data collection and interpretation would have been enhanced by use of a more
standardized physical activity questionnaire, quantifiable data that could be converted
into objective total exercise volume measures (such as MET-min/week) and, of course,
controlled laboratory conditions.
Much remains to be studied related to physical activity in individuals with T1D,
especially given the large number of variables that must be simultaneously balanced to
maintain normal or near normal glycemic levels. Future research likely should include the
potential implications of carbohydrate-restriction and other dietary patterns on physical
activity performance and glycemic balance in this population. Another area to pursue is
the glycemic benefits of using the latest technologies related to insulin delivery, glucose
monitoring, and physical activity trackers and other devices. Such technologies can provide
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immediate feedback to users and allow them to make optimal and real-time diabetes
regimen adjustments before, during, and after physical activity.
5. Conclusions
In conclusion, when individuals with type 1 diabetes of any age are already physically
active and their blood glucose is well-managed, a greater focus on lowering carbohydrate
intake may improve glycemic management. In addition, active individuals may benefit
from using continuous glucose monitoring to lower overall glycemia, especially when their
A1C values are higher than recommended. Nevertheless, all individuals can benefit from
being physically active on a regular basis, especially when the myriad variables affecting
glucose responses can be adequately managed to prevent hypoglycemia or hyperglycemia.
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Appendix A
Multiple selection methods used revealed that the participants’ usual carbohydrate
intake (“CarbIntake”) and use of CGM devices (“CGM”) factors were strong predictors
of their A1C values (Table A1). The corresponding model variance in the case of the
parsimonious simplified model (with CarbIntake and CGM use only) showed an estimate
of the model variance of σ̂2 = 0.7098177 (Table A2).
Table A1. A1C with CGM and CarbIntake as independent variables.
Source DF Type III SS Mean Square F Value Pr > F
CGM 1 3.92606553 3.92606553 5.53 0.0196
CarbIntake 3 16.96667395 5.6555798 7.97 <0.0001
Table A2. GLM with A1C as dependent variable.
Source DF Sum of Squares Mean Square F Value Pr > F
Model 4 22.2315103 5.5578776 7.83 <0.0001
Error 215 152.6108078 0.7098177
Corrected Total 219 174.8423182
R-Square Coeff Var Root MSE A1C Mean
0.127152 12.85111 0.842507 6.555909
To minimize that variance, a transformation of the A1C to natural log (base e) was
considered. When this log A1C was used, the same significant predictors (i.e., CGM and
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CarbIntake) were still obtained from the data (Table A3), but the parsimonious model
variance was reduced. The variance of the log A1C was σ̂2 = 0.0162 (Table A4), which was
more than 44 times smaller than the variance of the model with untransformed A1C. With
the reduced variance, the model precision increased.
Table A3. Log A1C with CGM and CarbIntake as independent variables.
Source DF Type III SS Mean Square F Value Pr > F
CGM 1 0.06910170 0.06910170 4.24 0.0407
CarbIntake 3 0.45376179 0.15125393 9.28 <0.0001
Table A4. GLM with log A1C as dependent variable.
Source DF Sum of Squares Mean Square F Value Pr > F
Model 4 0.55208798 0.13802199 8.47 <0.0001
Error 215 3.50378520 0.01629668
Corrected Total 219 4.05587317
R-Square Coeff Var Root MSE Log A1C Mean
0.136121 6.822330 0.127658 1.871185
Thus, the histogram and boxplots of log A1C with respect to the same predictors (e.g.,
sex, CarbIntake, insulin pump use, CGM, physical activity categories) were created. The
histogram plot showed of A1C data exhibited a gap, which led log A1C to have a narrower
distribution closer to a normal one than A1C (Figure A1).
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significant predictor under GLM for the A1C or its log was CarbIntake (Tables A7 and A8).
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Table A5. GLM with A1C < 7% as dependent variable.
Source DF Sum of Squares Mean Square F Value Pr > F
Model 4 7.01869591 1.75467398 5.21 0.0006
Error 149 50.16286253 0.33666351
Corrected Total 153 57.181555844
R-Square Coeff Var Root MSE A1C Mean
0.122744 9.453552 0.580227 6.137662
Table A6. GLM with log A1C < 1.95% (log < 7% equivalent) as dependent variable.
Source DF Sum of Squares Mean Square F Value Pr > F
Model 4 0.24412292 0.06103073 6.02 0.0002
Error 161 1.63114020 0.01013131
Corrected Total 165 1.87526312
R-Square Coeff Var Root MSE Log A1C Mean
0.130181 5.533238 0.100654 1.819086
Table A7. A1C < 7% with CGM and CarbIntake as independent variables.
Source DF Type III SS Mean Square F Value Pr > F
CGM 1 0.01272245 0.01272245 0.04 0.8461
CarbIntake 3 6.79896805 2.26632268 6.73 0.0003
Table A8. Log A1C < 1.95% with CGM and CarbIntake as independent variables.
Source DF Type III SS Mean Square F Value Pr > F
CGM 1 0.00018887 0.00018887 0.02 0.8916
CarbIntake 3 0.24281020 0.08093673 7.99 <0.0001
When the A1C was high (≥7%), the model variance went from 0.3440 (Table A9)
to 0.0055 (Table A10), a substantial almost 62-fold reduction. Moreover, the most signif-
icant predictor under GLM for the A1C or its log was CGM use (Tables A11 and A12,
respectively).
Table A9. GLM with A1C ≥ 7% as dependent variable.
Source DF Sum of Squares Mean Square F Value Pr > F
Model 4 6.87375483 1.71843871 4.99 0.0015
Error 61 20.98942699 0.34408897
Corrected Total 65 27.86318182
R-Square Coeff Var Root MSE A1C Mean
0.246697 7.788172 0.586591 7.531818
Table A10. GLM with log A1C ≥ 1.95% (log ≥ 7% equivalent) as dependent variable.
Source DF Sum of Squares Mean Square F Value Pr > F
Model 4 0.07311333 0.01827833 3.29 0.0181
Error 49 0.27183879 0.00554773
Corrected Total 53 0.34495212
R-Square Coeff Var Root MSE Log A1C Mean
0.211952 3.666696 0.074483 2.031341
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Table A11. A1C ≥ 7% with CGM and CarbIntake as independent variables.
Source DF Type III SS Mean Square F Value Pr > F
CGM 1 4.27150374 4.27150374 12.41 0.0008
CarbIntake 3 2.88369801 0.96123267 2.79 0.0478
Table A12. Log A1C ≥ 1.95% with CGM and CarbIntake as independent variables.
Source DF Type III SS Mean Square F Value Pr > F
CGM 1 0.05392963 0.05392963 9.72 0.0030
CarbIntake 3 0.031058040 0.01052680 1.90 0.1423
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